Journal of the Renin-Angiotensin-Aldosterone System · 2011 · 26 citations · 31 references
MedicineGeneticsGeriatric MedicineCardiovascular GeneticsGenetic EpidemiologyMedical GeneticsCardiovascular AgingCardiovascular DiseaseCardiovascular EpidemiologyCardiovascular RiskGenetic RiskAge-related Cardiac RiskAge-related Cardiovascular ChangesCardiovascular Genetic RiskCardiovascular Risk MarkersGel Electrophoresis
INTRODUCTION: A polymorphism in the angiotensin-converting enzyme gene (ACE I/D polymorphism) has been associated with increased risk for cardiovascular disease (CVD). This polymorphism affects the level of circulating ACE, but there is great individual variation, even between those with the same genotype. Few previous studies have investigated the link between circulating ACE and cardiovascular risk. The aim of this study was to investigate this association, and to examine the relationship between ACE level, ACE genotype and CVD. MATERIALS AND METHODS: The study population consisted of 322 men and 350 women aged 69-87. Plasma ACE level was determined using enzyme-linked immunosorbent assay (ELISA), and ACE genotype was analysed using PCR followed by gel electrophoresis. RESULTS: In men, ACE levels increased with increasing number of cardiovascular risk factors (p = 0.003). There was a significant association in men between increased ACE level and both diabetes (p = 0.007) and smoking (p = 0.037). CONCLUSIONS: This study shows that cardiovascular risk factors (such as smoking and diabetes) are associated with higher levels of circulating ACE in men. High ACE levels may represent one of the cellular mechanisms involved in producing the vascular damage associated with cardiovascular risk factors.
31
Brigitte Rigat, C. Hübert, F Alhenc‐Gelas et al. · Journal of Clinical Investigation · 1990 · 3.8K citations · Full text
Ramipril and the Development of Diabetes
Salim Yusuf · JAMA · 2001 · 546 citations · Full text